BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32661773)

  • 1. Increased phospholipase D activity contributes to tumorigenesis in prostate cancer cell models.
    Borel M; Cuvillier O; Magne D; Mebarek S; Brizuela L
    Mol Cell Biochem; 2020 Oct; 473(1-2):263-279. PubMed ID: 32661773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer-derived exosomes promote osteoblast differentiation and activity through phospholipase D2.
    Borel M; Lollo G; Magne D; Buchet R; Brizuela L; Mebarek S
    Biochim Biophys Acta Mol Basis Dis; 2020 Dec; 1866(12):165919. PubMed ID: 32800947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipase D inhibitors reduce human prostate cancer cell proliferation and colony formation.
    Noble AR; Maitland NJ; Berney DM; Rumsby MG
    Br J Cancer; 2018 Jan; 118(2):189-199. PubMed ID: 29136407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphatidic acid, phospholipase D and tumorigenesis.
    Gomez-Cambronero J
    Adv Biol Regul; 2014 Jan; 54():197-206. PubMed ID: 24103483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of phospholipase D during cultured osteoblast mineralization and bone formation.
    Abdallah D; Skafi N; Hamade E; Borel M; Reibel S; Vitale N; El Jamal A; Bougault C; Laroche N; Vico L; Badran B; Hussein N; Magne D; Buchet R; Brizuela L; Mebarek S
    J Cell Biochem; 2019 Apr; 120(4):5923-5935. PubMed ID: 30320913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
    Roth E; Frohman MA
    Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of choline for acetylcholine synthesis by phospholipase D isoforms.
    Zhao D; Frohman MA; Blusztajn JK
    BMC Neurosci; 2001; 2():16. PubMed ID: 11734063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of phospholipase D suppresses taxotere-induced cell death in stomach cancer cells.
    Cho JH; Hong SK; Kim EY; Park SY; Park CH; Kim JM; Kwon OJ; Kwon SJ; Lee KS; Han JS
    Biochim Biophys Acta; 2008 May; 1783(5):912-23. PubMed ID: 18190795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoregulation of phospholipase D activity is coupled to selective induction of phospholipase D1 expression to promote invasion of breast cancer cells.
    Kang DW; Park MH; Lee YJ; Kim HS; Lindsley CW; Alex Brown H; Min do S
    Int J Cancer; 2011 Feb; 128(4):805-16. PubMed ID: 20473892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of phospholipase D in parathyroid hormone type 1 receptor signaling and trafficking.
    Garrido JL; Wheeler D; Vega LL; Friedman PA; Romero G
    Mol Endocrinol; 2009 Dec; 23(12):2048-59. PubMed ID: 19837945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and regulation of phospholipase D isoforms in mammalian cell lines.
    Gibbs TC; Meier KE
    J Cell Physiol; 2000 Jan; 182(1):77-87. PubMed ID: 10567919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and regulation of human phospholipase D.
    Bowling FZ; Frohman MA; Airola MV
    Adv Biol Regul; 2021 Jan; 79():100783. PubMed ID: 33495125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phospholipase D2 in prostate cancer: protein expression changes with Gleason score.
    Noble AR; Hogg K; Suman R; Berney DM; Bourgoin S; Maitland NJ; Rumsby MG
    Br J Cancer; 2019 Dec; 121(12):1016-1026. PubMed ID: 31673104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Insights for Drugs Developed for Phospholipase D Enzymes.
    Stieglitz KA
    Curr Drug Discov Technol; 2018; 15(2):81-93. PubMed ID: 28814238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PLD-Specific Small-Molecule Inhibitors Decrease Tumor-Associated Macrophages and Neutrophils Infiltration in Breast Tumors and Lung and Liver Metastases.
    Henkels KM; Muppani NR; Gomez-Cambronero J
    PLoS One; 2016; 11(11):e0166553. PubMed ID: 27851813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phorbol ester stimulates ethanolamine release from the metastatic basal prostate cancer cell line PC3 but not from prostate epithelial cell lines LNCaP and P4E6.
    Schmitt J; Noble A; Otsuka M; Berry P; Maitland NJ; Rumsby MG
    Br J Cancer; 2014 Oct; 111(8):1646-56. PubMed ID: 25137020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of phospholipases D1 and 2 in astroglial proliferation: effects of specific inhibitors and genetic deletion.
    Burkhardt U; Beyer S; Klein J
    Eur J Pharmacol; 2015 Aug; 761():398-404. PubMed ID: 25967349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting Phospholipase D Genetically and Pharmacologically for Studying Leukocyte Function.
    Gomez-Cambronero J; Ganesan R
    Methods Mol Biol; 2018; 1835():297-314. PubMed ID: 30109659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phospholipase D in cell signaling: from a myriad of cell functions to cancer growth and metastasis.
    Gomez-Cambronero J
    J Biol Chem; 2014 Aug; 289(33):22557-22566. PubMed ID: 24990944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.